We are live on
!
Find out more
T
TOBAM Portfolio holdings
AUM
$384M
1-Year Est. Return
10.32%
This Fund
S&P 500
This Quarter
Est. Return
-8.27%
1 Year Est. Return
+10.32%
3 Year Est. Return
+36.67%
5 Year Est. Return
+41.37%
10 Year Est. Return
+233.72%
AUM
$2.08B
AUM Growth
-$266M
(-11%)
Cap. Flow
+$19.3M
Cap. Flow
% of AUM
0.93%
Top 10 Holdings %
Top 10 Hldgs %
29.17%
Holding
173
New
38
Increased
54
Reduced
63
Closed
18
Top Buys
| 1 |
GE Aerospace
GE
|
+$47.9M |
| 2 |
Tesla
TSLA
|
+$27.6M |
| 3 |
Newmont
NEM
|
+$20.3M |
| 4 |
Sempra
SRE
|
+$18.8M |
| 5 |
Eversource Energy
ES
|
+$18.1M |
Top Sells
| 1 |
SRCL
Stericycle Inc
SRCL
|
+$22.7M |
| 2 |
Regeneron Pharmaceuticals
REGN
|
+$19.3M |
| 3 |
lululemon athletica
LULU
|
+$15.6M |
| 4 |
Bristol-Myers Squibb
BMY
|
+$15.5M |
| 5 |
PG&E
PCG
|
+$14.9M |
Sector Composition
| 1 | Consumer Discretionary | 19.92% |
| 2 | Utilities | 17.87% |
| 3 | Consumer Staples | 13.46% |
| 4 | Healthcare | 9.93% |
| 5 | Industrials | 9.09% |
Similar funds
PCM
DFA
BAMG
DR
GCP
DC
GA
VI
TOBAM's Q4 2018 Portfolio in Review
As of Q4 2018, TOBAM held 173 positions worth $2.08B, down 11% from $2.34B the previous quarter. Its ten largest holdings account for 29% of the portfolio.
TOBAM's Q4 2018 filing shows 38 new, 54 increased, 63 reduced and 18 closed positions. Its largest new stake was DexCom: 556,052 shares worth $16.7M. The largest sale was Stericycle Inc, an estimated $22.7M.
By sector, the portfolio is most concentrated in Consumer Discretionary at 20% of assets, up from 19% a quarter earlier, followed by Utilities and Consumer Staples.
- TOBAM's largest Q4 2018 buy was DexCom: 556,052 shares worth $16.7M.
- TOBAM added most to GE Aerospace in Q4 2018, an estimated $47.9M increase.
- TOBAM's biggest Q4 2018 reduction was lululemon athletica, cutting an estimated $15.6M.
- TOBAM fully exited Stericycle Inc in Q4 2018, selling an estimated $22.7M.
- TOBAM's ten largest holdings make up 29% of its $2.08B portfolio in Q4 2018.
- TOBAM opened 38 new positions and closed 18 in Q4 2018.
- TOBAM's portfolio value fell 11% quarter-over-quarter to $2.08B.
Based on TOBAM's 13F filing for Q4 2018, filed 11 Feb 2019.